BioSpace News Archive

RedHill Biopharma Ltd. today announced that Mr. Guy Goldberg , RedHill’s Chief Business Officer, will present an overview of the Company and host 1-on-1 investor meetings at the following virtual conferences in November

Omega Therapeutics, Inc. today announced that Mahesh Karande , President will present at the Jefferies London Healthcare Conference on Wednesday, November 17, 2021 at 8:00 a.m. GMT.

Synlogic, Inc., a clinical-stage company bringing the transformative potential of synthetic biology to medicine, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the nomination of SYNB1353, an investigational Synthetic BioticTM medicine for the treatment of homocystinuria.

Braxia Scientific Corp. is delighted to announce that its CEO, Dr. Roger McIntyre, is joining KetaMD

Ionis Pharmaceuticals, Inc. announced that management will participate in virtual fireside chats at the following virtual investor conferences:.

Allurion Technologies today announced new clinical data on the Allurion Program presented at ObesityWeek® 2021.

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced it will participate in a fireside chat at the following investor conferences.

Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update

OnKure, Inc. today announced the appointment of Mark L. Boys, Ph.D., as Vice President of Discovery Chemistry.

Marinus Pharmaceuticals, Inc. today provided an update on its clinical and regulatory development activities and reported its financial results for the third quarter ended September 30, 2021.